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Abstract 
Aim: To outline the pathways a cohort of first attendees to our headache clinics had taken over the 
years in search of explanations and treatment for their headaches. To establish a greater 
awareness of the shortcomings and failures in their medical journey in the hope that better 
headache management will emerge in primary care. 
 
Background: At first attendance in primary care most headache sufferers will not receive a firm 
diagnosis. Treatments provided are often ineffective and so many patients embark on a somewhat 
random self-made journey searching for a remedy. If they reach a Headache Clinic the most 
common diagnoses are ‘chronic migraine’ and ‘medication overuse headache’. They are either no 
better or worse than when their headaches first started despite their efforts. 
 
Method: We undertook a prospective questionnaire-based study of over 200 patients on first 
attendance at each of our headache clinics, three based in District General Hospitals and one in a 
tertiary referral centre. We documented the patients’ headache characteristics, the ‘burden’ of their 
headaches, functional handicap and the financial costs incurred seeking help prior to referral. We 
also documented what our patients understood about their headache disorder and the treatments 
previously tried.   
 
Findings: Most patients had not been given a formal diagnosis in primary care and many remained 
unconvinced of the benign nature of their headache problem and wanted further investigations. 
Few had sought help from headache charities. Many had unrealistic attitudes to their problem and 
medication overuse was rife. Few patients had been offered triptans in primary care. Key 
deficiencies in the primary care management of these patients included failure to provide a formal 
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headache diagnosis, inadequate understanding of the nature and mechanism of headaches and 
failure to follow a resilient management strategy. We provide a more effective management 
pathway in primary care. 
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Headache is the commonest of all symptoms and probably a universal experience at some time of 
life. Primary headache syndromes, notably ‘migraine’ and ‘tension type headache’ as defined by 
the International Headache Classification (IHC, The International Classification of Headache 
Disorders, 3rd edition (beta version), 2013) affect more than 80% of the adult population in the UK. 
70% of people will experience a significant headache within a 3-month period with 20% reporting 
missed or reduced ability work days as a result (Steiner, 2003).  
It is not therefore surprising that headache is a frequent presenting symptom in primary care. 
About 3% of the general population consults primary care for headache each year making it the 
most common neurological presentation (Latinovic, 2006). ‘Chronic headache’ (chronic daily 
headache (CDH), defined under the IHC as attacks of headache occurring on more than half the 
days in a month over a period of more than three months affects 2-4% of the UK population 
(Stovner, 2007). CDH is very often ‘chronic migraine’, which nearly always develops from episodic 
migraine (Bigal, 2008) and nearly half of such cases also have potentially avoidable medication 
overuse headache (MOH) (Castillo, 1999).  
In worldwide terms headache is the third most common cause of disability (Steiner, 2015). 
Headache also has a significant social and economic impact.  According to the World Health 
Organisation, migraine is the fifth most common cause of ‘years lived with disability’ (WHO, 2012), 
ahead of diabetes and osteoarthritis (Vos, 2010), and the annual cost of headache disorders in the 
UK is estimated to be £5-7 billion (Steiner, 2010).  
If correctly diagnosed, nearly all headache patients can be managed in primary care, where 
common headache co-morbidities and the complex psychosocial factors that are often important in 
the provocation and perpetuation of headache can be addressed most effectively (The Association 
of British Neurologists,1993; Belam, 2005; Ridsdale, 2010). However, most adult migraineurs have 
never consulted their general practitioner despite high levels of disability (Thomas, 2004) and only 
2% of those seen in primary care are referred to a neurologist (Latinovic R, 2006). Of those who 
do present to their GP, 70% will receive no formal diagnosis and it has been suggested that GPs’ 
difficulties in diagnosing primary headache contribute to its morbidity and unmet need (Kernick, 
2008). In Kernick’s study only 5% received a diagnosis in first year after consultation and in 73% 
the diagnosis was ‘migraine’ (Kernick, 2008).  
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For many headache patients, pharmacists and opticians are alternative sources of advice and 
treatment and many patients self-manage (Peters, 2003). Others attend Accident and Emergency 
departments where migraine is the most common of all neurological presentations (Gahir, 2006).  
Very little is known of the journeys patients take before reaching one of the relatively few 
headache neurologists or specialist headache clinics in the UK. The authors all work in secondary 
or tertiary care and specialise in headache. When comparing our practices, we realised we were 
seeing similar ‘problem’ headache patients – mostly middle age women with long standing chronic 
migraine, usually previously undiagnosed and often complicated by MOH. Many were also taking 
migraine prophylactic medications that were clearly ineffective and had also seen a variety of 
healthcare practitioners with various qualifications in the search for a solution to their headache 
problem.  
We had no reason to believe that patients seen in other UK headache clinics would differ 
significantly from ours. We therefore decided to survey the patients referred to our practices using 
a questionnaire that we devised to see if our impressions were confirmed and if so, whether a 
more productive approach could be recommended. In particular, we examined the patients’ 
headache characteristics and the ‘burden’ of headache in terms of chronicity, functional handicap 
and financial costs incurred seeking a remedy prior to referral. We also documented what our 
patients understood about their headache disorder and the treatments they had tried previously.  
 
Methods 
We conducted a 6 month survey of consecutive new patients referred to specialist headache 
clinics at three district general hospitals (Northampton, York, and Ashford, Middlesex) and one 
tertiary referral centre (National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, 
London). Patients were invited to complete a ‘Headache Pathway’ questionnaire (see Appendix).  
In addition to demographic data, we documented: how long patients had suffered a headache 
problem before consulting a GP; the number of GP attendances before referral for expert opinion, 
time to referral, and whether they had episodic or chronic headache. We also recorded whether 
patients had been given a specific headache diagnosis by their GP and whether they wanted a 
brain scan and if so, why. We also asked which other health professionals they had consulted for 
headache management, how much money they estimated to have spent addressing their 
headache problem, and how much time off work or full-time education they had lost because of 
headaches. We documented the headache treatments they had received prior to referral and how 




209 questionnaires were completed (Northampton 46, York 43, Ashford 80 and NHNN 40). The 
respondents comprised 199 women and 10 men mean age 44.3 ± 15.6 (range 17-82 years). 




Headache characteristics and pre-referral diagnosis (Table 1) 
 
More patients had chronic than episodic headaches by a ratio of about 2:1 except in Northampton, 
where there were more patients with episodic headache. Of 200 responders, only 72 (36%) had 
been given a specific headache diagnosis prior to referral. Some patients underwent brain 
scanning via our headache clinics as a result of patient demand but no relevant intracranial 
abnormalities were found. Following assessment, all the patients were considered to fulfil criteria 
for the defined primary headache disorders, ‘episodic migraine’ or ‘CDH’, now considered to be 
‘chronic migraine’ (CM), sometimes complicated by MOH. (The International Classification of 
Headache Disorders, 3rd edition (beta version), 2013).  
 
Headache Burden (Tables 2 and 3) 
 
Headache history and visits to GPs 
 
Patients seen in the DGH clinics reported having headaches for between 6 to 10 years on average 
prior to referral. The mean duration was still longer (13.5 years) at the tertiary referral centre 
(NHNN). All patients reported consulting their GP on numerous previous occasions for headache 
management prior to referral. The lowest average number of visits was in York (8.5) and the 
highest at NHNN (14.8) 
.  
Time lost from work and full-time education 
 
124/196 respondents (63%) were in work or full-time education. Table 3 shows the headache 
‘burden’ in terms of time lost from work or education because of headache in the 12 months prior 
to survey. This ranged from an average of about 14 days in Northampton to 44 at NHNN.  
 
Private treatment costs 
 
In addition to seeking help through the NHS, many patients had paid for private treatment. Most 
had spent hundreds of pounds over the years (Table 3). The most common privately funded 
treatments were changes in glasses prescriptions and ‘alternative therapies’ (see below).  
 




Most patients (64%) had not been given a headache diagnosis by their GP. At NHNN, 40% knew 
that their diagnosis was ‘chronic migraine’. Of the 66 DGH clinic patients who provided responses, 
72% wanted a brain scan. This proportion was much less at the tertiary centre (only 2 of 31 
respondents) presumably because many had been scanned previously in primary or secondary 
care. The reasons given for wanting a brain scan varied. Some said “to find the cause of my 
headaches”, or “to get to the bottom of the problem”; some “because I’m worried” or “for 
reassurance”. Some did not know why they wanted a scan and some patients who had been 
scanned previously wanted another scan. 
 
Previous Sources of Medical Help (Table 5) 
 
In addition to consulting GPs on numerous occasions prior to referral, the majority of patients at all 
centres had also attended a wide range of other professionals, and some several. 62% had 
consulted an optician.  
Across the four centres less than 15% of patients were aware of the major UK Headache charities 
(The Migraine Trust and Migraine Action) which can be consulted for management advice and 
support. In Northampton only 5 patients knew of a headache charity (35 did not; 6 no answer); in 
York 5 were aware (30 were not; 7 no answer), and at Ashford just 4 patients knew of these 
charities (70 were not; 6 no answer). However, at NHNN, 19 patients were aware of the headache 
charities (17 were not; 4 no answer). 
 
Previous Drug Treatment and Treatment Responses (Table 6) 
 
Patients in all centres had tried a wide variety of analgesics to treat their headaches. The most 
commonly used was paracetamol, followed by ibuprofen and aspirin. Disconcertingly, nearly all 
patients had used Co-codamol and other opiate containing drugs frequently, regularly and often at 
high doses at some time. Although triptan use was quite common the reported treatment response 
was not impressive. The most frequently used prophylactic drugs were amitriptyline and 
propranolol followed by sodium valproate, topiramate and pizotifen.  The number of patients who 
became pain free after taking their acute treatment and the number who had previously tried 






Our study suggests that in England, the headache sufferer’s journey in search of explanation and 
treatment can be a long and frustrating one. Most patients referred to our expert clinics were 
middle aged women with frequent episodic headaches or chronic daily headache. ‘Migraine’ or 
‘chronic migraine’, often complicated by medication overuse, was the final diagnosis in almost all. 
Many of these patients had suffered headaches for a decade or more before referral and as a 
result had lost significant periods of time from work or full-time education. 
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Despite numerous previous consultations with their GPs only a third of the patients had been 
given a specific headache diagnosis prior to referral. This must surely have resulted in sub-optimal 
or incorrect treatment in many cases. In our experience, the first advice given for troublesome 
headaches in primary care is usually an assessment by an optician, although primary ophthalmic 
problems such as refractive errors are very rarely a cause of headaches in isolation (The 
International Classification of Headache Disorders, 3rd edition (beta version). 2013). Migraine in 
primary care is also often wrongly attributed to ‘sinusitis’ and treated as such (Al-Hashel JY, 2013).  
Without a correct diagnosis, patients can have little understanding as to the true nature of their 
headache problem and its mechanisms and this is likely to not only heighten anxieties as to 
causation but impede effective management.   
Although no pathological cause for headache was suspected or found in any patient in our study, 
many patients were anxious about undetected disease despite the chronicity of their headaches. 
Seventy-two percent wanted a brain scan, some even if they had been scanned previously. Many 
patients thought this would “get to the bottom of the problem” but there is no indication for such 
investigation in the vast majority of cases according to the many publications on “when to scan 
headache” (Ahmed, 2012). Scanning headache patients in primary care may reduce referrals to 
secondary care but rarely provides a diagnosis and is unlikely to help the longer-term 
management in primary care. Indeed, it may add to their anxieties (Howard, 2005). Packard 
concluded that in general, physicians overestimate patients’ wish for ‘headache treatment’ and 
underestimate their need to understand the basis of their headaches. More emphasis on diagnosis 
and explanation is clearly needed (Packard 1979). 
Although migraine was by far the most common diagnosis in our cohort, less than half the DGH 
patients had been offered triptans. In addition, only a minority enjoyed a satisfactory response to 
their acute treatment. Many actually had undiagnosed chronic migraine and prophylactic therapy 
should have been a key intervention in management. Although prophylactic drugs had been 
prescribed in a minority the treatment regimes had been largely ineffective. Many patients had 
therefore become over-reliant on analgesics. It is well recognised that analgesic overuse is a 
significant factor in headache chronicity and a frequent complication among problem headache 
clinic patients (Dowson, AJ, 2003). Opiates and compound analgesics are especially culpable and 
it was sobering to find that most patients in our study had used Co-codamol and other opiate 
based drugs frequently and on a regular basis despite widely published advice on the dangers of 
these drugs as a treatment for headache. BASH states that opiates and opioids (including 
diamorphine, morphine, pethidine, dextropropoxyphene, buprenorphine, tramadol, codeine and 
dihydrocodeine) “should be avoided” in acute migraine treatment (BASH, 2010).  
It is not surprising therefore that our patients looked to alternative resources for help. In addition to 
opticians, many had also sought the advice of physical therapists (physiotherapists, osteopaths 
and chiropractors) and had received treatment based on the concept of ‘neck therapies’ although 
there is little evidence for their effectiveness in the headache population (Biondi DM, 2005). 
Although we did not enquire how our patients had made their choices of alternative practitioners, 
patients had spent considerable amounts of money without benefit.  
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The majority of our patients had not consulted any of the UK headache charities for advice. These 
organisations provide excellent evidence based information not only for conditions like migraine 
but also with regard to the availability of headache services throughout the UK.  
In summary, our study showed high levels of unmet need and significant economic impact from 
primary headaches. Most headaches are benign but frequent attacks can be intrusive and 
disabling. Episodic and chronic migraine are by far the most common headache semiologies but a 
formal diagnosis at the outset supported by authoritative evidence is an essential part of 
management. There are many readily available evidence-based guidelines for headache 
management (National Institute for Health and Care Excellence, 2012; British Association for the 
Study of Headache, 2010; Scottish Intercollegiate Guidelines Network. Diagnosis and 
management of headache in adults), and chronic migraine (Weatherall, 2015). In our opinion, 
more frequent use of triptans instead of analgesics for episodic headaches and the early 
introduction of prophylactics with regular review and supervision during dose escalation at an early 
stage might reduce the tendency to develop chronic migraine and MOH. In addition, there is 
evidence that improved education for general practitioners supported by general practitioners with 
a special interest in headache (GPwSI) has the potential to significantly reduce the burden of 
headache in the UK. GPwSIs reduce costs as they order less head scans than non-specialist 
neurologists (Elliot, 2011). A healthcare system incorporating GPwSI has been described (Steiner, 
2011). Improvements in the management of headache in primary care in the UK are needed now 
to not only treat the type of patients we see most often in our headache clinics but to try and 
prevent the common complications that so often develop when the nature of headache is 
misunderstood and mismanaged.  
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Table 1 - Characteristics of patients’ headaches and pre-referral diagnosis.  
 
 
 Northampton York Ashford NHNN 
Duration of headache problem prior to 
referral (years) 
N=44 (2) 
8.6 ± 8.8 
 
N=43 (0) 
10.3 ± 14.1 
 
N=75 (5) 






Mean number of visits to GP before 
referral 
N = 41 (5) 
11.3 ± 11.2 
Mode=10 
N = 39 (3) 
8.53 ± 8.7 
Mode=8.7 
N = 59 (22) 
9.3 ± 15.3 
Mode=3 
N = 35 (7) 
14.8 ± 9.4 
Mode=10 
 
Table 2 - Headache years and number of GP visits prior to referral. (The number of patients who did not 




















16 no response 
No Data 15 episodic 
29 chronic 
30 no response 
9 episodic 
30 chronic 
1 no response 






26 no diagnosis 
5 no response 
20 diagnosed 
21 no diagnosis 
2 no response 
22 diagnosed 
57 no diagnosis 
1 no response 
15 diagnosed 
24 no diagnosis 








N = 44 (2) 
33 
N = 39 (4) 
24 
N = 73 (7) 
52 
N = 40 (0) 
15 
Days lost in last 
12 months? 
Mean =13.8 ± 
17.7 
Mean = 6.8 
±8.8 
Mean = 21.9 ± 
57.3 
Mean = 43.7 ± 98 
Estimated self-
financed 
treatment costs  
34 (12) 
£354 ± 382 
19 (23) 
£612 ± 1174 
56 (24) 
£421 ± 2777 
31 (9) 
£1935 ± 827 
 
Table 3 - Time lost from work or full-time education because of headache and private treatment costs. 













































































Table 6 - Use and response to acute treatment, including triptans, and previous use of migraine 
prophylactic drugs.  
 
 
 Northampton York Ashford NHNN 
Optician 29 of 46 (63%) 31 of 43 (72%) 54 of 89 (60%) 29 of 41 (71%) 
Physiotherapist 5 3 4 5 
Osteopath 3 4 3 10 
ENT clinic 1 1 6 8 
Chiropractor 3  1 6 12 
Dentist 7 2 19 14 
Acupuncturist 8 0 10 15 








Triptans  22 tried 
13 not tried 
11 no answer 
9 tried 
12 not tried 
23 no answer 
22 tried 
41 not tried 
19 no answer 
23 tried 
0 not tried 
19 no answer 
Pain free (more 






1 no answer 
13 pain-free 
27 not 
3 no answer 
11 pain-free 
69 not 
2 no answer 
4 pain-free 
35 not 
3 no answer 
Prophylactic 
treatment 
30 tried  
14 not tried 
2 no answer 
9 tried 
12 not tried 
23 no answer 
22 tried  
41 not tried 
19 no answer 
23 tried 
0 not tried 
19 no answer 
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Headache Journey Questionnaire 
Name ………………………………………………. 
Date of Birth ………………………………………. 
Hospital Number …………………………………. 
Final Diagnosis …………………………………… 
 
Please provide information requested or circle the correct answer where indicated 
 
1. How long have you been significantly troubled by headache? 
 ………months ……years 
How long did you have the headache problem before your GP referred you to the clinic? 
 ……… months ……years 
2. Do you have headache attacks – that is episodes of headache with no headache between 
attacks? 
 Yes No 




Do you have headache most of the time, or all day every day with or without additional more 
severe attacks? 
 Yes No 
If you have additional more severe attacks, how often do these more severe attacks occur? 
 ………times a week 
 
3. What do you understand to be the cause of your headache? 
 ………………………………………………………………… 
Was the cause of your headache diagnosed before you came to the Headache Clinic? 
14 
 
 Yes No 
If yes, by whom?...................................................... 
Are you worried that there may be a serious cause?    Yes     No 
Do you want a brain scan?      Yes       No 
If so, why?   ………………………………………………………… 
4. Before consulting us, how many times had you visited the following to try and resolve your 
headache problem? 
GP   Yes/No  …….times 
Optician  Yes/No  …….times 
Physiotherapist Yes/No  …….times 
Osteopath  Yes/No  …….times 
ENT Surgeon Yes/No  …….times 
Chiropractor  Yes/No  …….times 
Dentist  Yes/No  …….times 
Acupuncturist Yes/No  …….times 
Other (please state) Yes/No  …….times 
Did your GP suggest seeing any of the professionals listed above? If so, which? 
……………………………………………………………….. 
5. How much money do you think you have spent treating your headache (eg glasses, private 
consultations, private prescriptions, alternative medicine etc)? 
£……… 
6. Are you in paid employment/attend full-time education? 
Yes No 
If so, how much time have you lost from work or education because of your headache 
problem in the last 12 months? 
………….days 
7. Please tick any of the following drugs if you have ever used them to treat your headache. 
Aspirin  Codydramol 
Paracetamol  Co-codamol 
15 
 
Nurofen  Tramadol 
Imigran or other drug known as a triptan 
8. What drugs do you now take to treat your headache? Please state the name, number of tablets 




9. Do you achieve pain-free relief after you have taken your medication? 
Yes No Sometimes 
10. Have you ever used a daily medication to prevent rather than treat your headache? 
 Yes No 
Please tick any of the following drugs you have tried in order to prevent your headache. Did any of 
them reduce the frequency of the headache attacks? If so, by how much in percentage terms? 
Propranolol (Inderal)   ……………%reduction 
Pizotifen (Sanomigran)   ……………%reduction 
Sodium valproate (Epilim)   ……………%reduction 
Amitriptyline     ……………%reduction 
Topiramate (Topamax)   ……………%reduction 
11. Do you know of any Headache Charities in the UK? 
Yes No 
If so, which ones?............................................ 
12. What are your expectations from visiting our Headache Clinic? 
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
………………………………………………………………… 
 
Thank You 
 
 
 
 
